FAM
TNGX icon

Fred Alger Management’s Tango Therapeutics TNGX Stock Holding History

Fred Alger Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.14M Buy
+150,070
New +$2.09M 0.01% 276
2025
Q4 		– Sell
-230,316
Closed -$1.93M – 510
2025
Q3 		$1.93M Buy
230,316
+38,979
+20% +$264K 0.01% 323
2025
Q2 		$980K Buy
+191,337
New +$473K ﹤0.01% 356
2023
Q4 		– Sell
-47,337
Closed -$533K – 496
2023
Q3 		$533K Buy
+47,337
New +$289K ﹤0.01% 378

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Fred Alger Management's TNGX Position: Q1 2026 in Review

Fred Alger Management opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 150,070 shares worth $3.14M. The stake represents 0.01% of the portfolio and ranks #276 among its holdings. This is a return to the name: Fred Alger Management previously reported a position in TNGX as recently as Q3 2025.

Fred Alger Management first reported a position in TNGX in Q3 2023 and has held it in 4 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Fred Alger Management held 150,070 shares of Tango Therapeutics worth $3.14M as of Q1 2026.
  • Tango Therapeutics was a new Fred Alger Management position in Q1 2026.
  • Tango Therapeutics made up 0.01% of Fred Alger Management's portfolio in Q1 2026, its #276 holding.
  • Fred Alger Management first reported a position in Tango Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.